Avita Medical | 1811094D - 销售和管理费用

股票价格
1.23
每天变化
0.09 7.93%
每月一次
-12.50%
每年
-46.97%
Q2 预测
1.15


金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 149.45M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


销售和管理费用 更改 日
Accuray USD 124.78M 2.54M 2025-12
Celltrion KRW 12.71B 237.27B 2025-12
Clinuvel Pharmaceuticals AUD 3.85M 5.27M 2025-12
Cochlear AUD 449.4M 214.45M 2025-12
CSL USD 1.23B 498M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Mayne Pharma AUD 54.8M 11.94M 2024-06
Medical Developments International AUD 2.84M 4.19M 2025-12
Nanosonics AUD 53.78M 26.93M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Ovoca Bio EUR 632K 2.33M 2025-06
Pacific Edge NZD 19.17M 1.32M 2025-12
Paradigm Biopharmaceuticals AUD 2.83M 1.22M 2025-12
Pharma Mar EUR 15.31M 2M 2026-03
Polynovo AUD 17.04M 1.91M 2025-12
PYC Therapeutics AUD 328.4K 1.8M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 275.7M 16.51M 2025-12
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Telix Pharmaceuticals AUD 93.48M 1.04M 2025-12
Tilray USD 24.85M 1.7M 2025-09
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03